NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

反轉錄病毒迅速檢驗·POC - 醫療設備的開發平台評估

Retrovirus Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 975178
出版日期 內容資訊 英文 85 Pages
訂單完成後即時交付
價格
反轉錄病毒迅速檢驗·POC - 醫療設備的開發平台評估 Retrovirus Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年11月30日內容資訊: 英文 85 Pages
簡介

本報告提供反轉錄病毒迅速檢驗的開發中產品調查分析,以各開發階段比較分析為焦點,提供包含正開發管道產品的主要企業,進行中的臨床試驗相關之系統性資訊

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 反轉錄病毒迅速檢驗·POC - 開發中產品:各開發階段
  • 反轉錄病毒迅速檢驗·POC - 開發中產品:各地區
  • 反轉錄病毒迅速檢驗·POC - 開發中產品:各法規途徑
  • 反轉錄病毒迅速檢驗·POC - 開發中產品:各核准預定日

第4章 反轉錄病毒迅速檢驗·POC - 正在開發的管道產品:各企業

  • 反轉錄病毒迅速檢驗·POC企業 - 開發中產品:各開發階段
  • 反轉錄病毒迅速檢驗·POC - 開發中產品:各開發階段

第5章 反轉錄病毒迅速檢驗·POC企業與產品概要

  • Akers Biosciences Inc

第6章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1051EPD

GlobalData's Medical Devices sector report, "Retrovirus Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Retrovirus Rapid Tests are the diagnostic tests used for rapid diagnosis, with immediate results to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Retrovirus Rapid Tests & POC under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Retrovirus Rapid Tests & POC and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Retrovirus Rapid Tests & POC under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Retrovirus Rapid Tests & POC Overview

3 Products under Development

  • 3.1 Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development
  • 3.2 Retrovirus Rapid Tests & POC - Pipeline Products by Territory
  • 3.3 Retrovirus Rapid Tests & POC - Pipeline Products by Regulatory Path
  • 3.4 Retrovirus Rapid Tests & POC - Pipeline Products by Estimated Approval Date

4 Retrovirus Rapid Tests & POC - Pipeline Products under Development by Companies

  • 4.1 Retrovirus Rapid Tests & POC Companies - Pipeline Products by Stage of Development
  • 4.2 Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development

5 Retrovirus Rapid Tests & POC Companies and Product Overview

  • 5.1 Akers Biosciences Inc Company Overview

6 Appendix

  • 6.1 Methodology
  • 6.2 About GlobalData
  • 6.3 Contact Us
  • 6.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development
  • Table 2: Retrovirus Rapid Tests & POC - Pipeline Products by Territory
  • Table 3: Retrovirus Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Table 4: Retrovirus Rapid Tests & POC - Pipeline Products by Estimated Approval Date
  • Table 5: Retrovirus Rapid Tests & POC Companies - Pipeline Products by Stage of Development
  • Table 6: Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development
  • Table 7: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: PIFA HIV 1+2 Rapid Assay - Product Status

List of Figures

List of Figures

  • Figure 1: Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development
  • Figure 2: Retrovirus Rapid Tests & POC - Pipeline Products by Territory
  • Figure 3: Retrovirus Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Figure 4: Retrovirus Rapid Tests & POC - Pipeline Products by Estimated Approval Date